Frazier Life Sciences X, L.p. - Net Worth and Insider Trading
Frazier Life Sciences X, L.p. Net Worth
The estimated net worth of Frazier Life Sciences X, L.p. is at least $108 Million dollars as of 2024-12-29. Frazier Life Sciences X, L.p. is the 10% Owner of MBX Biosciences Inc and owns about 4,552,774 shares of MBX Biosciences Inc (MBX) stock worth over $91 Million. Frazier Life Sciences X, L.p. is also the 10% Owner of HilleVax Inc and owns about 8,544,187 shares of HilleVax Inc (HLVX) stock worth over $17 Million. Details can be seen in Frazier Life Sciences X, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frazier Life Sciences X, L.p. has not made any transactions after 2024-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Frazier Life Sciences X, L.p.
Frazier Life Sciences X, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frazier Life Sciences X, L.p. owns 3 companies in total, including Frazier Lifesciences Acquisition Corp (FLAC) , HilleVax Inc (HLVX) , and Frazier Lifesciences Acquisition Corp (FLACU) .
Click here to see the complete history of Frazier Life Sciences X, L.p.’s form 4 insider trades.
Insider Ownership Summary of Frazier Life Sciences X, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FLAC | Frazier Lifesciences Acquisition Corp | 2020-12-08 | director |
| HLVX | HilleVax Inc | 2024-04-04 | 10 percent owner |
| FLACU | Frazier Lifesciences Acquisition Corp | 2020-12-08 | director |
Frazier Life Sciences X, L.p. Latest Holdings Summary
Frazier Life Sciences X, L.p. currently owns a total of 2 stocks. Among these stocks, Frazier Life Sciences X, L.p. owns 4,552,774 shares of MBX Biosciences Inc (MBX) as of September 16, 2024, with a value of $91 Million and a weighting of 84.64%. Frazier Life Sciences X, L.p. also owns 8,544,187 shares of HilleVax Inc (HLVX) as of April 4, 2024, with a value of $17 Million and a weighting of 15.36%.
Latest Holdings of Frazier Life Sciences X, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MBX | MBX Biosciences Inc | 2024-09-16 | 4,552,774 | 20.07 | 91,374,174 |
| HLVX | HilleVax Inc | 2024-04-04 | 8,544,187 | 1.94 | 16,575,723 |
Holding Weightings of Frazier Life Sciences X, L.p.
Frazier Life Sciences X, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Frazier Life Sciences X, L.p. has made a total of 1 transactions in MBX Biosciences Inc (MBX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in MBX Biosciences Inc is the acquisition of 625,000 shares on September 16, 2024, which cost Frazier Life Sciences X, L.p. around $10 Million.
According to the SEC Form 4 filings, Frazier Life Sciences X, L.p. has made a total of 2 transactions in HilleVax Inc (HLVX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in HilleVax Inc is the acquisition of 8,850 shares on April 4, 2024, which cost Frazier Life Sciences X, L.p. around $128,325.
Insider Trading History of Frazier Life Sciences X, L.p.
- 1
Frazier Life Sciences X, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Frazier Life Sciences X, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frazier Life Sciences X, L.p. is -19.85%. GuruFocus also compares Frazier Life Sciences X, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Frazier Life Sciences X, L.p. within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frazier Life Sciences X, L.p.'s insider trading performs compared to the benchmark.
Performance of Frazier Life Sciences X, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.18 | | | | | |
| Relative Return to S&P 500(%) | -15.76 | | | | | |
Frazier Life Sciences X, L.p. Ownership Network
Frazier Life Sciences X, L.p. Owned Company Details
What does Frazier Lifesciences Acquisition Corp do?
Who are the key executives at Frazier Lifesciences Acquisition Corp?
Frazier Life Sciences X, L.p. is the director of Frazier Lifesciences Acquisition Corp. Other key executives at Frazier Lifesciences Acquisition Corp include director & Chief Financial Officer David Joseph Topper , 10 percent owner & other: Possible Member of 10% Group James E Flynn , and 10 percent owner & other: Possible Member of 10% Group Deerfield Partners, L.p. .
Frazier Lifesciences Acquisition Corp (FLAC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Frazier Lifesciences Acquisition Corp (FLAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frazier Lifesciences Acquisition Corp Insider Transactions
Frazier Life Sciences X, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Frazier Life Sciences X, L.p.. You might contact Frazier Life Sciences X, L.p. via mailing address: 601 Union Street, Suite 3200, Two Union Square, Seattle Wa 98101.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
